SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product -- Ignore unavailable to you. Want to Upgrade?

To: Doug Bean who wrote (1063)4/3/1999 9:34:00 PM
From: KM  Read Replies (1) | Respond to of 1837
 
Tamoxifen was originally derived from a plant source but is now produced synthetically, I believe. I've just begun to see advertisements aimed at women to take a standardized breast cancer risk assessment test for possible use of it prophylactically if their risk factors are high enough. This would have to be an ever increasing market as the baby boom generation of women ages and their breast cancer risk increases.

Very interesting stuff.



To: Doug Bean who wrote (1063)4/4/1999 12:02:00 PM
From: OpusX  Respond to of 1837
 
doug, Paclitaxel is the drug made from yew trees not tamoxifen tamoxifen is a hormonal product



To: Doug Bean who wrote (1063)4/4/1999 6:36:00 PM
From: JEB  Read Replies (1) | Respond to of 1837
 
Doug,

That thump you just heard was my head and the wall. I can't believe I didn't see this one earlier. These guys are 20 minutes driving time from my house, off I-75 and Norwood Exit. This company used to be more heavily into generic drugs. At least it is a slow rally. I'm doing some DD on DRMD now and looking at the chart for a buy point (If everything checks out). -IMO-

Good trading,
JEB


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News